AMANDA BEHNEN: Open Payments
NPI 1356900492 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 114 payments from 16 companies in 2025. Trend: 2023 $1,793 · 2024 $2,372 · 2025 $1,621
Food & beverage: $1,621
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $261 |
| Amgen Inc. | 12 | $236 |
| GENZYME CORPORATION | 8 | $161 |
| Janssen Biotech, Inc. | 11 | $159 |
| Organon LLC | 22 | $148 |
| Botanix SB Inc | 25 | $143 |
| LEO Pharma Inc. | 4 | $142 |
| Lilly USA, LLC | 4 | $99 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Arcutis Biotherapeutics, Inc. | 3 | $55 |
Products named: Bimzelx, Otezla, DUPIXENT, TREMFYA, SOFDRA, VTAMA, TALTZ, ANZUPGO.
Industry payments across MO — which companies pay providers there.
